Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06699680 · ClinicalTrials.gov registry record · Phase 1
Phase 1 Study of PRX019 in Healthy Adult Volunteers
A Phase 1 study of Healthy Participants Study, sponsored by Prothena Biosciences.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 48
- Enrollment target
- 1
- Study location
NCT06699680 is a Phase 1 study of Healthy Participants Study that is actively recruiting participants, run by Prothena Biosciences. The registered enrollment target is 48 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06699680, a Phase 1 study of Healthy Participants Study, is actively recruiting participants, sponsored by Prothena Biosciences.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess the safety and tolerability of PRX019 in healthy adult participants.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG PRX019
Study Locations (1)
California
- Local Institution - Los Alamitos
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2024-11-08 |
| Est. Completion | 2026-01-23 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06699680
The ClinicalTrials.gov registry entry for NCT06699680 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Prothena Biosciences, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy Participants Study appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06699680 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06699680 about?
NCT06699680 is a clinical study titled "Phase 1 Study of PRX019 in Healthy Adult Volunteers". The purpose of this study is to assess the safety and tolerability of PRX019 in healthy adult participants.
What is the current status of trial NCT06699680?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 48 participants. The study started on 2024-11-08. Estimated completion is 2026-01-23.
What conditions does trial NCT06699680 study?
This clinical trial studies the following conditions: Healthy Participants Study.
What interventions are being tested in trial NCT06699680?
The interventions under investigation include: Placebo (DRUG), PRX019 (DRUG).
Who is sponsoring clinical trial NCT06699680?
This trial is sponsored by Prothena Biosciences, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06699680 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.